Stereotaxis

Yahoo Finance • 18 days ago

Stereotaxis expects annual revenue to surpass $40M with Q3 and Q4 above $10M as MAGiC and Synchrony ramp

Earnings Call Insights: Stereotaxis, Inc. (STXS) Q1 2026 MANAGEMENT VIEW * "Stereotaxis has had an amazing start to this year" and management framed Q1 as a period where "our reported quarterly numbers don't yet reflect it," while citi... Full story

Yahoo Finance • 18 days ago

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as EuropeSynchrony digital operating room system received U.S. FDA clearanc... Full story

Yahoo Finance • last month

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 202... Full story

Yahoo Finance • last month

Stereotaxis Announces Definitive Agreement to Acquire Robocath

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a defin... Full story

Yahoo Finance • 2 months ago

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

What happened According to an SEC filing dated February 17, 2026, DAFNA Capital Management LLC reduced its stake in iShares Biotechnology ETF(NASDAQ:IBB) by 34,405 shares during the fourth quarter of 2025. The fund’s quarter-end IBB posit... Full story

Yahoo Finance • 3 months ago

Earnings week ahead: ORCL, ADBE, LI, NIO, HPE, ZIM, KSS, and more

[Business finance report sales analysis] alexsl Despite a relatively light earnings calendar, the upcoming earnings week will offer investors a broad look across multiple sectors, from technology and EVs to retail, mining, and biotech, as... Full story

Yahoo Finance • 6 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

ST. LOUIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the company will participate in the Piper Sand... Full story

Yahoo Finance • 7 months ago

Biggest stock movers Wednesday: AMD, ALC, and more

[Currency and Exchange Stock Chart for Finance and Economy Display] cemagraphics Stock futures inched higher on Wednesday, driven by increasing optimism about the imminent end of the federal government shutdown. Investors responded positi... Full story

Yahoo Finance • 7 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

ST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025... Full story

Yahoo Finance • 7 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE Mark in Europe and submitted a 510(k... Full story

Yahoo Finance • 8 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

ST. LOUIS and MARLBOROUGH, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device comp... Full story

Yahoo Finance • 8 months ago

ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan... Full story

Yahoo Finance • 8 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

ST. LOUIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful first procedures by physicians at Erasm... Full story

Yahoo Finance • 9 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the successful completion of the world’s first pro... Full story

Yahoo Finance • 9 months ago

Stereotaxis to Present at Upcoming Investor Conferences

ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will present... Full story

Yahoo Finance • 9 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025

ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology will be featured during the upcoming... Full story

Yahoo Finance • 9 months ago

Shield Therapeutics reports positive results for heart failure drug

LONDON - Shield Therapeutics plc (LSE:STX) announced positive results from a clinical study showing its oral iron treatment FeRACCRU® (ferric maltol) improved outcomes in patients with heart failure and iron deficiency anemia. The ORION-H... Full story

Yahoo Finance • 10 months ago

Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum

Earnings Call Insights: Stereotaxis (STXS) Q2 2025 MANAGEMENT VIEW * CEO David Leo Fischel described 2025 as “a pivotal milestone-rich year in which we advance a broad portfolio of strategic innovations to market and demonstrate their... Full story

Yahoo Finance • 10 months ago

Stereotaxis Inc (NYSEARCA:STXS) Q2 2025 Earnings: Revenue Surpasses Forecasts, Losses Narrower Than Expected

STEREOTAXIS INC (NYSE:STXS) Q2 2025 EARNINGS: REVENUE BEATS ESTIMATES, LOSSES NARROWER THAN EXPECTED Stereotaxis Inc (NYSE:STXS [https://www.chartmill.com/stock/quote/STXS/profile]), a leader in robotic surgical systems for minimally inva... Full story

Yahoo Finance • 10 months ago

Stereotaxis' MAGiC Sweep Catheter Receives FDA 510(k) Clearance For Complex Arrhythmia Treatment

(RTTNews) - Stereotaxis, Inc. (STXS), Monday announced it has received U.S. Food and Drug Administration 510(k) clearance for its MAGiC Sweep catheter, the first ever robotically navigated high-density electrophysiology mapping catheter to... Full story